Intravenous Infusions (XGHA:IIL) Long-Term Capital Lease Obligation : GHS0.00 Mil (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Long-Term Capital Lease Obligation?

Intravenous Infusions's Long-Term Capital Lease Obligation for the quarter that ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Long-Term Capital Lease Obligation Historical Data

The historical data trend for Intravenous Infusions's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Long-Term Capital Lease Obligation Chart

Intravenous Infusions Annual Data

Trend

Long-Term Capital Lease Obligation

Intravenous Infusions Semi-Annual Data

Long-Term Capital Lease Obligation

Intravenous Infusions (XGHA:IIL) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Intravenous Infusions Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.